Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2017-02-09 Major Shareholding Noti…
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
SEC SCHEDULE 13G
Major Shareholding Notification
2017-02-09 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-08 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-08 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-08 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 6, 2017, reporting the appointment of a new director to the company's board. The key section is Item 5.02, which specifically addresses the departure and election of directors and officers. The content focuses on the appointment of Dr. Stephen N. Oesterle to the board and related compensation details. This matches the definition of Board/Management Information filings, which announce changes in the company's board of directors or senior management. The document is not a full annual report, audit report, or earnings release, nor is it a proxy solicitation or voting results announcement. Therefore, the appropriate classification is MANG (Board/Management Information). The confidence is high given the clear and explicit content of the filing.
2017-02-08 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 1, 2017, by Baxter International Inc. It reports the issuance of an earnings press release for the quarterly and annual periods ended December 31, 2016. The text specifically mentions that the press release is furnished as Exhibit 99.1 and contains financial measures including non-GAAP metrics. The document is primarily an announcement of the earnings release rather than the full earnings report itself. The length is 4870 characters, which is relatively short and consistent with an earnings release announcement. Therefore, the document fits best into the Earnings Release (ER) category, as it announces quarterly and annual financial results with key highlights and non-GAAP measures, typical of an earnings release.
2017-02-01 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.